Ubs Group Ag Aslan Pharmaceuticals LTD Transaction History

Ubs Group Ag

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$0.36 - $24.24 $222 - $14,956	617 Added 38.56%	2,217 $0
Q3 2022 Nov 10, 2022	BUY	$0.42 - $24.68 $672 - $39,488	1,600 New	1,600 $1,000
Q2 2022 Aug 10, 2022	SELL	$0.36 - $0.9 $2,292 - $5,732	-6,369 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.74 - $1.22 $4,713 - $7,770	6,369 New	6,369 $6,000
Q4 2021 Feb 14, 2022	SELL	$1.11 - $1.86 $13,090 - $21,934	-11,793 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.78 - $3.41 $13,401 - $25,673	7,529 Added 176.57%	11,793 $21,000
Q2 2021 Aug 13, 2021	BUY	$2.5 - $3.72 $9,172 - $13,648	3,669 Added 616.64%	4,264 $14,000
Q1 2021 May 12, 2021	SELL	$1.86 - $5.25 $1,210 - $3,417	-651 Reduced 52.25%	595 $2,000
Q4 2020 Feb 11, 2021	BUY	$1.54 - $2.22 $1,918 - $2,766	1,246 New	1,246 $2,000
Q3 2020 Nov 12, 2020	SELL	$1.41 - $2.04 $2,112 - $3,055	-1,498 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$0.96 - $2.19 $2,386 - $5,444	-2,486 Reduced 62.4%	1,498 $3,000
Q1 2020 May 01, 2020	BUY	$0.93 - $2.8 $3,565 - $10,735	3,834 Added 2556.0%	3,984 $4,000
Q4 2019 Feb 14, 2020	SELL	$0.37 - $5.2 $1,452 - $20,420	-3,927 Reduced 96.32%	150 $0
Q3 2019 Nov 14, 2019	BUY	$1.51 - $3.85 $1,751 - $4,466	1,160 Added 39.77%	4,077 $7,000
Q2 2019 Aug 14, 2019	SELL	$2.91 - $4.5 $1,329 - $2,056	-457 Reduced 13.54%	2,917 $9,000
Q1 2019 May 14, 2019	SELL	$3.1 - $4.8 $1,215 - $1,881	-392 Reduced 10.41%	3,374 $14,000
Q4 2018 Feb 14, 2019	BUY	$2.86 - $8.0 $10,770 - $30,128	3,766 New	3,766 $14,000

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.